Concepedia

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer

M. Penz, Gabriela Kornek, Markus Raderer, H. Ulrich-Pur, Wolfgang Fiebiger, A. Lenauer, D. Depisch, G. Krauss, Werner Scheithauer

Annals of Oncology · 2001 · 176 citations · 13 references

DOI

Concepts

References

13

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

, , +10

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

, , +16

The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

Edmund A. Gehan · Journal of Chronic Diseases · 1961 · 670 citations

, , +3

Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.

Frank V. Fossella, S. M. Lippman, Dong M. Shin et al. · Journal of Clinical Oncology · 1997 · 130 citations

, , +15

Approximate Confidence Intervals for Probabilities of Survival and Quantiles in Life-Table Analysis

James R. Anderson, Leslie Bernstein, Malcolm C. Pike · Biometrics · 1982 · 81 citations

, , +16